Position in GRFS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$424
-$57 QoQ
Shares Held
60
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 164 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $61,006,231 across 17 Drug Manufacturers - General names. GRFS ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,661 | $20,231,503 | |
| 2 | MRK |
Merck & Co., Inc.
|
92,939 | $11,942,661 | |
| 3 | LLY |
ELI LILLY & Co
|
9,506 | $11,401,781 | |
| 4 | ABBV |
AbbVie Inc.
|
31,546 | $7,938,235 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,766 | $4,480,876 | |
| 6 | AMGN |
Amgen Inc
|
6,994 | $2,532,667 | |
| 7 | PFE |
Pfizer Inc
|
66,244 | $1,595,154 | |
| 8 | AZN |
Astrazeneca PLC
|
2,117 | $401,425 |
All Filings in GRFS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424 | 60 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $481 | 60 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1 | 60 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||